AUSTIN, Texas, June 03, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage: With oncology drug-development expenses continuing to rise and regulatory approvals becoming harder to secure, ...
The next article I wanted to discuss for the Biotech Analysis Central Model 10+ Portfolio Old Pick #17 is a biotech by the name of Tempest Therapeutics (TPST). I want to state that I have chosen to ...
The next article I wanted to discuss for the Biotech Analysis Central Model 10+ Portfolio Pick #18 is a biotech by the name of Annovis Bio (ANVS)The reason why I wanted to go over this biotech next as ...
INDIANAPOLIS, Sept. 9, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the launch of Lilly TuneLab, an artificial intelligence and machine learning (AI/ML) platform that ...
Big pharma shares its machine learning models with biotechs, but awaits definitive data on success of artificial intelligence-generated drugs. You have full access to ...
In collaboration with The Column Group, TCG Labs Soleil runs a venture-biotech model with its own R&D hub. (iStock/Getty Images Plus) TCG Labs Soleil has secured $400 million to boost the firm’s ...
Zacks Investment Research on MSNOpinion
Biotech's silent resurgence (5-year base breakout)
Biotech’s Brutal Bear Market Starting in early 2021, the notoriously difficult-to-invest-in biotech sector suffered one of ...
Biotechnology organizations are turning in growing numbers to alternative strategies centered on strengthening the performance of already-approved drugs. Oncotelic Therapeutics is developing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results